Table I.
Not all virus infections or pro-inflammatory stimuli sensitize bystander CD8 T cells1
Virus infection or pro-inflammatory stimulus | ||||
---|---|---|---|---|
TCR Tg | LCMV | PV | VV | Poly(I:C) |
P14 | N/A | 5.8±4 | 1.1±0.09 | 5.8±5 |
HY | 0.93±0.13 | 0.96±0.04 | 0.5±0.5 | 0.66±0.3 |
OT-I | 2.9±2 | 1.7±0.6 | 1.2±0.4 | 2.1±0.2 |
P14, HY, or OT-I transgenic CD8 T cells were adoptively transferred into naïve congenic recipients followed by inoculation with 5×104 pfu LCMV, 1.5×107 pfu PV, 1×106 pfu VV, or 200 µg poly(I:C) i.p. At day 5 post infection or day 1 post poly(I:C) inoculation, splenocytes were stimulated with GP33–41, Smcy, or SIINFEKL peptides ex vivo. Each transgenic population was gated and the ability of the transgenic T cells to produce IFN-γ in response to their cognate peptide was assessed. Numbers depict the average ratio of IFN-γ production from infected/treated mice over IFN-γ production from naïve/untreated mice stimulated with cognate peptide ± standard deviation from >30 total experiments.